产品管线
| 项目/目标 | 适应症 | 创新成果 | 先导化合物优化 |
IND申报支持性研究 |
I期临床 | II期临床 | III期临床 | 国家/地区 |
|---|
FWD1802SERD |
ER+ Breast Cancer |
|
|
|||||
FWD1802SERD(联合用药) |
ER+ Breast Cancer |
|
|
|||||
UNDISCLOSED |
KRAS G12C |
|
||||||
UNDISCLOSED |
KRAS G12D |
|
||||||
UNDISCLOSED |
FGFR2 |
|
||||||
UNDISCLOSED |
HPK1 |
|
||||||
FWB1313 |
IL13 |
|
||||||
FWB19144 |
FGFR2b |
|
||||||
FWB2114 |
New Target |
|
||||||